JP2001523961A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001523961A5 JP2001523961A5 JP1998546437A JP54643798A JP2001523961A5 JP 2001523961 A5 JP2001523961 A5 JP 2001523961A5 JP 1998546437 A JP1998546437 A JP 1998546437A JP 54643798 A JP54643798 A JP 54643798A JP 2001523961 A5 JP2001523961 A5 JP 2001523961A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4514897P | 1997-04-30 | 1997-04-30 | |
| US60/045,148 | 1997-04-30 | ||
| US6371597P | 1997-10-29 | 1997-10-29 | |
| US60/063,715 | 1997-10-29 | ||
| PCT/CA1998/000394 WO1998049311A2 (en) | 1997-04-30 | 1998-04-30 | Ricin-like toxin variants for treatment of cancer, viral or parasitic infections |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2001523961A JP2001523961A (ja) | 2001-11-27 |
| JP2001523961A5 true JP2001523961A5 (cg-RX-API-DMAC7.html) | 2007-01-11 |
| JP4566290B2 JP4566290B2 (ja) | 2010-10-20 |
Family
ID=26722431
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP54643798A Expired - Lifetime JP4566290B2 (ja) | 1997-04-30 | 1998-04-30 | 癌、ウイルスまたは寄生虫感染を治療するためのリシン様毒素変異体 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US6593132B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP0977862B8 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4566290B2 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE437229T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU7023798A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2288943C (cg-RX-API-DMAC7.html) |
| DE (1) | DE69840998D1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO1998049311A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6361946B1 (en) | 1997-02-05 | 2002-03-26 | Licentia Ltd | Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof |
| US7247715B2 (en) * | 1997-04-30 | 2007-07-24 | Twinstrand Therapeutics Inc. | Ricin-like toxin variants for treatment of cancer, viral or parasitic infections |
| AU7636800A (en) | 1999-10-04 | 2001-05-10 | Twinstrand Therapeutics Inc. | Improved ricin-like toxins for treatment of cancer |
| GB0100551D0 (en) * | 2001-01-09 | 2001-02-21 | Queen Mary & Westfield College | Protein |
| EP1483298A4 (en) | 2002-02-11 | 2007-03-14 | Zymogenetics Inc | MATERIALS AND METHODS FOR PREPARING DIMERED GROWTH FACTORS |
| AU2004257206A1 (en) * | 2003-07-10 | 2005-01-27 | Wyeth Holdings Corporation | Recombinant expression of Streptococcus pyogenes cysteine protease and immunogenic compositions thereof |
| EP1730282A4 (en) * | 2004-03-24 | 2007-05-09 | Twinstrand Therapeutics Inc | GLYCOSYLATION VARIANTS OF RICINE-LIKE PROTEINS |
| ATE467641T1 (de) * | 2004-03-26 | 2010-05-15 | Molecular Templates Inc | Bibliothek von toxin mutanten und deren verwendung |
| US20060024722A1 (en) * | 2004-07-30 | 2006-02-02 | Mark Fischer-Colbrie | Samples for detection of oncofetal fibronectin and uses thereof |
| DE102005002978B4 (de) * | 2005-01-21 | 2013-04-25 | Merz Pharma Gmbh & Co. Kgaa | Rekombinante Expression von Proteinen in einer disulfidverbrückten, zweikettigen Form |
| CA2664549A1 (en) | 2005-09-26 | 2007-03-29 | University Health Network | Library from toxin mutants, and methods of using same |
| DE602006012358D1 (de) * | 2005-11-18 | 2010-04-01 | Dabur Pharma Ltd | Zielgerichtete fusionsproteine für die krebstherapie |
| WO2008157263A2 (en) * | 2007-06-15 | 2008-12-24 | Arkansas State University | Methods of delivery of molecules to cells using a ricin subunit and compositions relating to same |
| EP2379720B1 (en) | 2009-01-20 | 2016-08-17 | Alona Zilberberg | Mir-21 promoter driven targeted cancer therapy |
| US9321847B2 (en) * | 2010-09-20 | 2016-04-26 | Ramot At Tel Aviv University Ltd. | Activatable toxin complexes comprising a cleavable inhibitory peptide |
| US10513539B2 (en) | 2011-02-10 | 2019-12-24 | Ruprecht-Karls-Universitat Heidelberg | Hydrophobic modified peptides and their use for liver specific targeting |
| CN103402546B (zh) | 2011-02-10 | 2018-04-13 | 海德堡鲁普雷希特卡尔斯大学 | 用于肝特异性诊断的疏水性修饰肽 |
| WO2012123755A1 (en) | 2011-03-17 | 2012-09-20 | The University Of Birmingham | Re-directed immunotherapy |
| JP7134461B2 (ja) * | 2018-03-23 | 2022-09-12 | 国立大学法人金沢大学 | マラリア治療剤、マラリア予防剤及び抗マラリア自然免疫賦活剤 |
| KR102698801B1 (ko) | 2020-12-30 | 2024-08-29 | 호크아이 바이오 리미티드 | 바이오마커 검출을 위한 순수 그래핀 기반 바이오센서 및 관련 코어 입자, 재료 구성 방법 및 시스템 |
| TW202328170A (zh) * | 2021-09-14 | 2023-07-16 | 美商艾希利歐發展股份有限公司 | 可裂解連接子 |
| WO2025151752A1 (en) | 2024-01-10 | 2025-07-17 | Xilio Development, Inc. | Masked il-2 cytokines and methods of use thereof |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2442A (en) | 1842-02-01 | Floating dry-dock | ||
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| EP0145111B1 (en) * | 1983-07-15 | 1990-05-09 | The University Of Warwick | Dna sequence coding for a plant toxin of the ricin type, or a portion thereof |
| US4736866B1 (en) | 1984-06-22 | 1988-04-12 | Transgenic non-human mammals | |
| JPS6147500A (ja) | 1984-08-15 | 1986-03-07 | Res Dev Corp Of Japan | キメラモノクロ−ナル抗体及びその製造法 |
| EP0173494A3 (en) | 1984-08-27 | 1987-11-25 | The Board Of Trustees Of The Leland Stanford Junior University | Chimeric receptors by dna splicing and expression |
| GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| US4869903A (en) | 1987-05-29 | 1989-09-26 | Genelabs Incorporated | Method of selectively inhibiting HIV |
| WO1990010457A1 (en) | 1989-03-14 | 1990-09-20 | New York University | Method of treating hiv infections using immunotoxins |
| US5128460A (en) | 1989-04-04 | 1992-07-07 | Genelabs Incorporated | Recombinant trichosanthin and coding sequence |
| US5101025A (en) | 1989-04-04 | 1992-03-31 | Genelabs Incorporated | Recombinant trichosanthin and coding sequence |
| US5248606A (en) * | 1990-06-11 | 1993-09-28 | Dowelanco | Dna encoding inactive precursor and active forms of maize ribosome inactivating protein |
| GB9021679D0 (en) | 1990-10-05 | 1990-11-21 | Gorman Scott David | Antibody preparation |
| US5677274A (en) * | 1993-02-12 | 1997-10-14 | The Government Of The United States As Represented By The Secretary Of The Department Of Health And Human Services | Anthrax toxin fusion proteins and related methods |
| EP0909322B1 (en) * | 1996-04-30 | 2005-11-16 | Twinstrand Therapeutics Inc. | Antiviral ricin-like proteins |
-
1998
- 1998-04-30 US US09/403,752 patent/US6593132B1/en not_active Expired - Lifetime
- 1998-04-30 JP JP54643798A patent/JP4566290B2/ja not_active Expired - Lifetime
- 1998-04-30 AT AT98916743T patent/ATE437229T1/de not_active IP Right Cessation
- 1998-04-30 DE DE69840998T patent/DE69840998D1/de not_active Expired - Lifetime
- 1998-04-30 CA CA2288943A patent/CA2288943C/en not_active Expired - Fee Related
- 1998-04-30 AU AU70237/98A patent/AU7023798A/en not_active Abandoned
- 1998-04-30 EP EP98916743A patent/EP0977862B8/en not_active Expired - Lifetime
- 1998-04-30 WO PCT/CA1998/000394 patent/WO1998049311A2/en not_active Ceased
-
2003
- 2003-03-24 US US10/394,511 patent/US7375186B2/en not_active Expired - Fee Related
-
2008
- 2008-04-29 US US12/111,407 patent/US20110144004A1/en not_active Abandoned